drugset / Trial / NCT01195363

Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder

NCT01195363

RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the acute and long-term bimodal efficacy of QTP, as an adjunct to ongoing treatment with lithium (Li) or divalproex (DIV) or lamotrigine (LAM) or any combination of the three thereof, in a group of patients with an index episode of a mixed state in BD.

Timeline

Start
2007-04
Primary completion
2010-12
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Quetiapine Small molecule Oral

Indications